Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

MARYLAND GENERAL HOSPITAL INC

NPI: 1669565180 · BALTIMORE, MD 21201 · Chronic Disease Hospital · NPI assigned 10/02/2006

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official SPRINKEL, GEORGE controls 15+ related entities in our dataset. Read more

$3.33M
Total Medicaid Paid
115,487
Total Claims
94,461
Beneficiaries
100
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialSPRINKEL, GEORGE (SR VP AND CHIEF FINANCIAL OFFICER)
NPI Enumeration Date10/02/2006

Related Entities

Other providers sharing the same authorized official: SPRINKEL, GEORGE

ProviderCityStateTotal Paid
UNIVERSITY OF MARYLAND MEDICAL CENTER, LLC BALTIMORE MD $18.03M
UNIVERSITY OF MARYLAND MEDICAL CENTER, LLC BALTIMORE MD $16.54M
UNIVERSITY OF MARYLAND MEDICAL CENTER, LLC BALTIMORE MD $10.19M
UNIVERSITY OF MARYLAND MEDICAL CENTER, LLC BALTIMORE MD $9.24M
MARYLAND GENERAL HOSPITAL, INC. BALTIMORE MD $7.12M
UNIVERSITY OF MARYLAND MIDTOWN HEALTH INC BALTIMORE MD $3.15M
MARYLAND GENERAL CLINICAL PRACTICE GROUP, INC. BALTIMORE MD $1.38M
UNIVERSITY OF MARYLAND MEDICAL CENTER, LLC BALTIMORE MD $1.07M
UNIVERSITY OF MARYLAND MEDICAL CENTER, LLC LINTHICUM MD $804K
MARYLAND GENERAL HOSPITAL, INC. BALTIMORE MD $524K
MARYLAND GENERAL CLINICAL PRACTICE GROUP, INC. BALTIMORE MD $395K
UNIVERSITY OF MARYLAND MEDICAL CENTER, LLC BALTIMORE MD $210K
UNIVERSITY OF MARYLAND MEDICAL CENTER, LLC BALTIMORE MD $193K
UNIVERSITY OF MARYLAND MEDICAL CENTER, LLC BALTIMORE MD $59K
UNIVERSITY OF MARYLAND MEDICAL CENTER, LLC BALTIMORE MD $0.00

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 24,248 $191K
2019 24,847 $451K
2020 12,620 $592K
2021 16,924 $607K
2022 14,820 $534K
2023 13,123 $554K
2024 8,905 $404K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
G0463 Hospital outpatient clinic visit for assessment and management of a patient 30,815 25,678 $1.23M
99284 Emergency department visit for the evaluation and management, high severity 4,783 4,324 $705K
99283 Emergency department visit for the evaluation and management, moderate severity 3,673 2,987 $317K
G0378 Hospital observation service, per hour 657 581 $221K
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 1,054 985 $202K
90832 Psychotherapy, 30 minutes with patient 5,894 4,520 $174K
90834 Psychotherapy, 45 minutes with patient 2,633 1,822 $113K
29581 745 225 $76K
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis 34 13 $53K
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes 244 229 $38K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) 38 26 $31K
45380 Colonoscopy, flexible; with biopsy, single or multiple 46 40 $25K
92014 Ophthalmological services: medical examination and evaluation, comprehensive, established patient 518 485 $23K
88305 Level IV - Surgical pathology, gross and microscopic examination 674 635 $14K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 349 330 $12K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 849 686 $11K
92012 Ophthalmological services: medical examination and evaluation, intermediate, established patient 604 560 $9K
97597 76 51 $9K
71046 Radiologic examination, chest; 2 views 1,594 1,480 $8K
92083 27 26 $6K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 16 12 $5K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1,237 1,068 $4K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 708 629 $4K
84484 1,889 1,402 $3K
90750 43 41 $3K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 191 177 $3K
84100 2,782 1,950 $3K
83036 Hemoglobin; glycosylated (A1C) 3,905 3,764 $2K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 448 380 $2K
90662 119 119 $2K
J2704 Injection, propofol, 10 mg 3,714 2,398 $2K
92133 76 74 $2K
99281 Emergency department visit for the evaluation and management, self-limited or minor 1,335 987 $2K
97161 97 91 $2K
70450 Computed tomography, head or brain; without contrast material 470 432 $2K
92004 Ophthalmological services: medical examination and evaluation, comprehensive, new patient 70 65 $2K
G0008 Administration of influenza virus vaccine 782 748 $2K
92134 36 26 $2K
80053 Comprehensive metabolic panel 5,366 4,340 $1K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 126 38 $782.31
90694 87 80 $716.96
85025 Blood count; complete (CBC), automated, and automated differential WBC count 4,920 4,033 $657.72
84443 Thyroid stimulating hormone (TSH) 590 559 $625.09
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 997 806 $544.52
J7030 Infusion, normal saline solution , 1000 cc 2,531 2,259 $541.06
74177 Computed tomography, abdomen and pelvis; with contrast material 66 63 $531.65
90732 13 12 $445.32
83735 4,070 2,843 $293.60
80048 Basic metabolic panel (calcium, ionized) 1,828 1,177 $243.21
81003 163 156 $200.07
90686 517 488 $176.69
83690 1,559 1,388 $166.37
J3010 Injection, fentanyl citrate, 0.1 mg 1,867 1,712 $154.00
J7050 Infusion, normal saline solution, 250 cc 1,087 758 $137.16
81001 2,586 2,281 $131.11
71045 Radiologic examination, chest; single view 888 698 $128.94
84703 86 77 $117.32
85730 1,016 836 $114.21
85027 1,460 906 $113.98
85610 1,617 1,221 $112.52
J7120 Ringers lactate infusion, up to 1000 cc 1,269 1,166 $92.67
J2250 Injection, midazolam hydrochloride, per 1 mg 1,719 1,615 $87.67
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 459 423 $83.85
J2405 Injection, ondansetron hydrochloride, per 1 mg 1,409 1,252 $76.71
86850 42 38 $66.39
80061 Lipid panel 78 76 $55.90
83605 299 225 $23.74
J0690 Injection, cefazolin sodium, 500 mg 442 382 $20.92
86901 42 38 $20.72
86900 42 38 $20.72
J2270 Injection, morphine sulfate, up to 10 mg 131 94 $14.58
J1885 Injection, ketorolac tromethamine, per 15 mg 330 310 $5.82
94760 206 136 $0.00
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 74 72 $0.00
83880 101 88 $0.00
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 42 40 $0.00
G0009 Administration of pneumococcal vaccine 13 12 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 64 53 $0.00
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 166 156 $0.00
82043 38 37 $0.00
J1100 Injection, dexamethasone sodium phosphate, 1 mg 182 173 $0.00
90480 135 134 $0.00
J1170 Injection, hydromorphone, up to 4 mg 16 13 $0.00
90656 15 15 $0.00
J2371 Injection, phenylephrine hydrochloride, 20 micrograms 12 12 $0.00
86803 12 12 $0.00
84439 240 226 $0.00
71250 17 14 $0.00
91320 135 135 $0.00
J1644 Injection, heparin sodium, per 1000 units 448 161 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 126 111 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 139 121 $0.00
J1650 Injection, enoxaparin sodium, 10 mg 77 37 $0.00
82570 89 88 $0.00
J1596 Injection, glycopyrrolate, 0.1 mg 26 25 $0.00
94726 13 13 $0.00
94729 12 12 $0.00
90853 Group psychotherapy (other than of a multiple-family group) 93 69 $0.00
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 35 31 $0.00
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 34 31 $0.00